Abstract
AbstractPleural mesothelioma (PM) is an aggressive disease that has a strong causal relationship with asbestos exposure and represents a major challenge from both a diagnostic and therapeutic viewpoint. Despite recent improvements in patient care, PM typically carries a poor outcome, especially in advanced stages. Therefore, a timely and effective diagnosis taking advantage of currently available imaging techniques is essential to perform an accurate staging and dictate the most appropriate treatment strategy. Our aim is to provide a brief, but exhaustive and up-to-date overview of the role of multimodal medical imaging in the management of PM.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference64 articles.
1. Mott FE. Mesothelioma: a review. Ochsner J. 2012;12:70–9.
2. Cardinale L, Ardissone F, Gned D, Sverzellati N, Piacibello E, Veltri A. Diagnostic imaging and workup of malignant pleural mesothelioma. Acta Biomed. 2017;88:134–42.
3. Neri E, Gabelloni M, Bäuerle T, Beets-Tan R, Caruso D, D’Anastasi M, et al. Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European society of oncologic imaging. Eur Radiol. 2021;31:983–91.
4. Armato SG 3rd, Francis RJ, Katz SI, Ak G, Opitz I, Gudmundsson E, et al. Imaging in pleural mesothelioma: a review of the 14th International conference of the international mesothelioma interest group. Lung Cancer. 2019;130:108–14.
5. International Agency for Research on Cancer. Mesothelioma. Source: globocan 2020. https://gco.iarc.fr/today/data/factsheets/cancers/18-Mesothelioma-fact-sheet.pdf. Accessed 31 Jul 2023.